Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

70 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Immunotherapy of human tumour xenografts overexpressing the EGF receptor with rat antibodies that block growth factor-receptor interaction.
Modjtahedi H, Eccles S, Box G, Styles J, Dean C. Modjtahedi H, et al. Br J Cancer. 1993 Feb;67(2):254-61. doi: 10.1038/bjc.1993.49. Br J Cancer. 1993. PMID: 7679281 Free PMC article.
The antibodies, ICR16 (IgG2a), ICR62 (IgG2b) and ICR64 (IgG1), have been shown (Modjtahedi et al., 1993) to be potent inhibitors of the growth in vitro of a number of human squamous cell carcinomas because they block receptor-ligand interaction. ...
The antibodies, ICR16 (IgG2a), ICR62 (IgG2b) and ICR64 (IgG1), have been shown (Modjtahedi et al., 1993) to be potent inhibitors of t …
Immunotherapy with antibodies to the EGF receptor.
Dean C, Modjtahedi H, Eccles S, Box G, Styles J. Dean C, et al. Int J Cancer Suppl. 1994;8:103-7. doi: 10.1002/ijc.2910570722. Int J Cancer Suppl. 1994. PMID: 8194887
Monoclonal antibodies to the EGF receptor act as betacellulin antagonists.
Modjtahedi H, Dean C. Modjtahedi H, et al. Biochem Biophys Res Commun. 1996 Apr 25;221(3):625-30. doi: 10.1006/bbrc.1996.0646. Biochem Biophys Res Commun. 1996. PMID: 8630011
Anti-EGFR monoclonal antibodies which act as EGF, TGF alpha, HB-EGF and BTC antagonists block the binding of epiregulin to EGFR-expressing tumours.
Modjtahedi H, Komurasaki T, Toyoda H, Dean C. Modjtahedi H, et al. Int J Cancer. 1998 Jan 19;75(2):310-6. doi: 10.1002/(sici)1097-0215(19980119)75:2<310::aid-ijc22>3.0.co;2-f. Int J Cancer. 1998. PMID: 9462724
EGFR blockade by tyrosine kinase inhibitor or monoclonal antibody inhibits growth, directs terminal differentiation and induces apoptosis in the human squamous cell carcinoma HN5.
Modjtahedi H, Affleck K, Stubberfield C, Dean C. Modjtahedi H, et al. Int J Oncol. 1998 Aug;13(2):335-42. doi: 10.3892/ijo.13.2.335. Int J Oncol. 1998. PMID: 9664130
Vascular endothelial growth factor family members are differentially regulated by c-erbB signaling in head and neck squamous carcinoma cells.
O-charoenrat P, Rhys-Evans P, Modjtahedi H, Eccles SA. O-charoenrat P, et al. Clin Exp Metastasis. 2000;18(2):155-61. doi: 10.1023/a:1006764100867. Clin Exp Metastasis. 2000. PMID: 11235991
70 results
Jump to page
Feedback